Showing results (161-170 of 690) with videos related to
Sort By:
Pageof 69
Studies in Health Technology and Informatics|October 23, 2023
Defining a Preprocessing Pipeline for the MULTI-SITA Project and General Medical Italian Natural Language DataAlice Cappello, Sara Mora, Daniele Roberto Giacobbe, et al.BMC Pulmonary Medicine|March 6, 2014
Resource use by patients hospitalized with community-acquired pneumonia in Europe: analysis of the REACH studyHelmut Ostermann, Javier Garau, Jesús Medina, et al.The Journal of Antimicrobial Chemotherapy|March 31, 2007
Cost-effectiveness of empirical prescribing of antimicrobials in community-acquired pneumonia in three countries in the presence of resistanceMonique Martin, Sibilia Quilici, Thomas File, et al.Respiratory Research|April 17, 2013
Current management of patients hospitalized with community-acquired pneumonia across Europe: outcomes from REACHFrancesco Blasi, Javier Garau, Jesús Medina, et al.Enfermedades Infecciosas Y Microbiologia Clinica|December 6, 2005
[Risk factors and prognostic factors in nosocomial pneumonia outside the intensive care units setting]Bienvenido Barreiro-López, Josep Maria Tricas, Elisabeth Mauri, et al.Enfermedades Infecciosas Y Microbiologia Clinica|February 7, 2009
[The infectious disease specialty in Europe and America]Jesús Rodríguez-Baño, Julio Arrizabalaga, Juan Berenguer, et al.Journal of Medical Economics|July 2, 2014
Resource use in patients hospitalized with complicated skin and soft tissue infections in Europe and analysis of vulnerable groups: the REACH studyHelmut Ostermann, Francesco Blasi, Jesús Medina, et al.International Journal of Antimicrobial Agents|September 26, 2002
The efficacy and safety of oral pharmacokinetically enhanced amoxycillin-clavulanate 2000/125 mg, twice daily, versus oral amoxycillin-clavulanate 1000/125 mg, three times daily, for the treatment of bacterial community-acquired pneumonia in adultsPatrick Petitpretz, Christian Chidiac, Francisco Soriano, et al.Respiratory Research|January 24, 2014
Early versus later response to treatment in patients with community-acquired pneumonia: analysis of the REACH studyFrancesco Blasi, Helmut Ostermann, Jill Racketa, et al.Clinical Case Reports|August 25, 2021
Kaposi-Juliusberg Varicelliform Eruption complicating Darier disease: May cannabinoid abuse be an underestimated risk factor?Roberto Russo, Laura Labate, Emanuele Cozzani, et al.Pageof 69